Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER
Research Comparison

5-Amino-1MQ vs IGF-1 LR3

5-Amino-1MQ and IGF-1 LR3 are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Metabolic
ClassSmall-molecule NNMT inhibitor (methylquinolinium salt) — not a peptideRecombinant 83-residue protein analogue of IGF-1
Molecular weightNot specifiedNot specified
CAS numberNot assigned / not specifiedNot assigned / not specified
Purity spec≥99%≥99%
Research areasMetabolic, Cellular LongevityHormonal & Endocrine, Metabolic, Musculoskeletal
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Dilute acetic acid (0.1 M) or 10 mM HCl — required for initial dissolution
Working windowCommonly worked with for several weeks at 2-8 °C in preserved diluent.Short: commonly worked with within 1–2 weeks at 2–8 °C, or frozen in single-use aliquots.
Lead degradation routeMicrobial growth in non-preserved diluent — a container problem rather than a molecular one.Denaturation and aggregation — the dominant failure mode, and one that has no equivalent in short unstructured peptides.
Freeze–thawTolerant of freeze-thaw — there is no tertiary structure to lose. Aliquoting is still good practice to limit repeated exposure of the stock.Single-use aliquots are the standard practice, and here it genuinely matters. IGF-1 LR3 has tertiary structure to lose — unlike the unstructured short peptides in this catalogue, it can denature, and denaturation is not reversible on rewarming.
Light sensitivityNo specific light requirement beyond normal practice.No specific light requirement beyond normal practice.

How they actually differ

Comparing the two: 5-Amino-1MQ is small-molecule nnmt inhibitor (methylquinolinium salt) — not a peptide, while IGF-1 LR3 is recombinant 83-residue protein analogue of igf-1 — different molecular classes with different handling consequences; they call for different primary diluents (bacteriostatic water (0.9% benzyl alcohol) versus dilute acetic acid (0.1 m) or 10 mm hcl — required for initial dissolution); their leading degradation routes differ (microbial growth in non-preserved diluent for 5-Amino-1MQ, denaturation and aggregation for IGF-1 LR3), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

5-Amino-1MQ — origin

5-Amino-1MQ is a small quinolinium molecule characterised as a first-in-class inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme studied at the intersection of adipocyte metabolism and the cellular NAD+/methylation pool. It is not an amino-acid chain, which is why it sits apart from every peptide in this catalogue.

IGF-1 LR3 — origin

IGF-1 LR3 is an engineered analogue carrying two changes to native IGF-1: an arginine substitution at position 3 and a 13-residue N-terminal extension. The Arg3 substitution is the functional one — it drastically reduces binding to IGF binding proteins, which normally sequester the great majority of circulating IGF-1. The result is a molecule that stays free rather than bound.

5-Amino-1MQ research themes

NNMT inhibition

The defining mechanism — preclinical work has examined how blocking NNMT shifts methylation flux and NAD+ salvage in metabolic tissue models.

Adipocyte energy metabolism

Studied in fat-cell models for effects on cellular energy handling and lipid metabolism.

NAD+ economy

Because NNMT consumes a methyl group tied to the NAD+ precursor pool, it is studied alongside the wider NAD+ research field.

IGF-1 LR3 research themes

IGFBP evasion

The Arg3 substitution reduces binding-protein affinity, which is the entire design rationale.

Cell proliferation

Widely used in cell-culture research as a growth-factor supplement.

Satellite cell activation

Studied in muscle-biology research models.

PI3K/Akt signalling

The canonical downstream pathway examined in IGF-1 receptor research.

5-Amino-1MQ handling

  • Let the sealed vial reach room temperature before opening so moisture does not condense onto the powder.
  • For cell-based assays, prepare a concentrated DMSO stock and dilute into aqueous buffer rather than dissolving directly at high concentration in medium.
  • Label aliquots with reconstitution date and diluent.

IGF-1 LR3 handling

  • Dissolve in dilute acetic acid or dilute HCl FIRST; do not attempt direct dissolution in water or PBS.
  • Add carrier protein (e.g. 0.1% BSA) for storage of dilute solutions to prevent adsorptive loss.
  • Prepare single-use aliquots — freeze–thaw denaturation is irreversible.
  • Do not vortex; agitation denatures folded proteins at the air–liquid interface.

Both third-party tested

Every Popular Peptides batch of 5-Amino-1MQ and IGF-1 LR3 is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

Verify a batchPublished COAsHow we test

5-Amino-1MQ reference

Full 5-Amino-1MQ reference 5-Amino-1MQ storage 5-Amino-1MQ reconstitution 5-Amino-1MQ calculator5-Amino-1MQ product details

IGF-1 LR3 reference

Full IGF-1 LR3 reference IGF-1 LR3 storage IGF-1 LR3 reconstitution IGF-1 LR3 calculatorIGF-1 LR3 product details

Related comparisons

5-Amino-1MQ vs CJC-1295 (No DAC)5-Amino-1MQ vs CJC-1295 + Ipamorelin5-Amino-1MQ vs DSIP5-Amino-1MQ vs Epitalon5-Amino-1MQ vs GLOW5-Amino-1MQ vs IGF-15-Amino-1MQ vs Ipamorelin5-Amino-1MQ vs KGLOW

5-Amino-1MQ and IGF-1 LR3 are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.